XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.81

0.0%

Nov 24 3:58 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (14760)	9/20/2000 5:51:59 AM
From: Robert K.	Read Replies (2) of 17367

I will repeat again. Baxter KNEW the data BEFORE doing the deal. As did others. Baxter jumped higher. Baxter has said on record the potential of bpi(if successful in meningo) was far in excess of 500mil, xoma has said all along that bpi shows a benefit. Xoma does say trauma didnt work. Xoma is a quiet and secretive company at times. Xoma caution is sometimes interputed as failure. The data is the data. As I have said all along, the data will speak. The data has spoken. I believe the FDA will do the right thing (thats a guess of mine). I am fustrated that delays equal causualties. I hope the process "does right" in a speedy manner. end.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next